stent

(redirected from endovascular stent)
Also found in: Dictionary, Thesaurus, Medical.
Related to endovascular stent: Stent Graft, EVAR

stent

Medicine a tube of plastic or sprung metal mesh placed inside a hollow tube to reopen it or keep it open; uses in surgery include preventing a blood vessel from closing, esp after angioplasty, and assisting healing after an anastomosis
References in periodicals archive ?
Andersen, "Management of carotid 'blowout' with endovascular stent grafts," The Laryngoscope, vol.
Endovascular stent implantation for coarctation of the aorta in children and young adults: intermediate follow-up results from Turkey.
the aneurysm should arise at least 5 mm beyond the LSA) with 'first-generation' endovascular stents and inadequate vascular access.
The company's lead product, Aorfix, is an endovascular stent graft which has been specifically designed to solve the problems that exist in treating complex tortuous anatomies, which are often present in advanced AAA disease.
The success of endovascular stent grafts for AAAs has provided motivation to adapt similar technology for descending TAAs and type B dissections.
Medical device company Lombard Medical (NasdaqGM:EVAR) said on Wednesday that an 89-year-old male with a 64mm aneurysm and challenging 75 degree aortic neck angulation was treated with its Aorfix Endovascular Stent Graft in Girona, Spain under its ARCHYTAS global registry programme.
Aorfix is the first and only endovascular stent graft approved in Japan to treat AAAs in patients with aortic neck angulations up to 90 degrees, commonly considered to be challenging cases.
Medical device company Lombard Medical (NasdaqGM:EVAR) disclosed on Monday the receipt of the US Food and Drug Administration's (FDA) clearance to expand its manufacturing operations at its new cleanroom in the UK for its Aorfix endovascular stent graft for AAA repair.
M2 EQUITYBITES-April 23, 2015-Lombard Medical treats first patient with aortic neck angulation with its Aorfix Endovascular Stent Graft in Girona, Spain
17 January 2012 - Lombard Medical Technologies Plc (LON:LMT), a UK-based manufacturer of endovascular stent grafts and other vascular products, announced on Tuesday that Ian Ardill was appointed as its chief financial officer with effect from 23 January 2012.
Aorfix is an endovascular stent graft which has been specifically designed to solve the problems that exist in treating complex tortuous anatomy which is often present in advanced abdominal aortic aneurysm (AAA) disease.
According to the company, it will continue to build out the US sales team as it expands its commercial footprint into the single largest endovascular stent graft market.